Data / Drug companies / Dextroamphetamine sulfate
Dextroamphetamine sulfate: 17 companies and 56 products in the FDA NDC directory
Dextroamphetamine sulfate is listed in the FDA National Drug Code Directory by 17 companies, with 56 products in commercial distribution. 50 of the products (89.3%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; capsule, extended release; solution, and the newest product started marketing on August 20, 2022.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 17
- Products
- 56
- Generic (ANDA) products
- 50 (89.3%)
- Application numbers
- 13
- Controlled substance schedule
- Schedule II
- Routes
- Oral
- Brand names
- Zenzedi, Dexedrine Spansule, Procentra
- openFDA record search
- api.fda.gov
Companies that list dextroamphetamine sulfate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Azurity Pharmaceuticals, Inc. | 7 | tablet | Generic drugs (ANDA) | May 1, 2014 |
| Bryant Ranch Prepack | 7 | tablet | Generic drugs (ANDA) | August 6, 2021 |
| Winder Laboratories LLC | 7 | tablet | Generic drugs (ANDA) | December 6, 2021 |
| SpecGx LLC | 5 | capsule, extended release; tablet | Generic drugs (ANDA) | May 6, 2003 |
| Wilshire Pharmaceuticals, Inc. | 5 | tablet | Generic drugs (ANDA) | August 6, 2021 |
| Actavis Pharma, Inc. | 3 | capsule, extended release | Generic drugs (ANDA) | June 19, 2014 |
| Amneal Pharmaceuticals LLC | 3 | capsule, extended release | New drug applications (NDA) | August 2, 1976 |
| Amneal Pharmaceuticals of New York LLC | 3 | capsule, extended release | Authorized generics (NDA) | August 2, 1976 |
| Aurolife Pharma, LLC | 2 | tablet | Generic drugs (ANDA) | July 31, 2013 |
| Bryant Ranch Prepack | 2 | tablet | Generic drugs (ANDA) | July 4, 2018 |
| Cranbury Pharmaceuticals, LLC | 2 | tablet | Generic drugs (ANDA) | August 20, 2022 |
| KVK-Tech, Inc. | 2 | tablet | Generic drugs (ANDA) | November 23, 2015 |
| Lupin Pharmaceuticals,Inc. | 2 | tablet | Generic drugs (ANDA) | April 25, 2016 |
| Sunrise Pharmaceutical, Inc. | 2 | tablet | Generic drugs (ANDA) | July 4, 2018 |
| Teva Pharmaceuticals USA, Inc. | 2 | tablet | Generic drugs (ANDA) | February 12, 2001 |
| Independence Pharmaceuticals, LLC | 1 | solution | Generic drugs (ANDA) | May 15, 2014 |
| Prasco Laboratories | 1 | solution | Generic drugs (ANDA) | May 15, 2014 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 42 | 75% |
| Capsule, extended release | 12 | 21.4% |
| Solution | 2 | 3.6% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 50 | 89.3% |
| New drug applications (NDA) | 3 | 5.4% |
| Authorized generics (NDA) | 3 | 5.4% |
Pharmacologic classes
| Class | Products |
|---|---|
| Central Nervous System Stimulant | 56 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.